When a scientist discovered a new technology out of the incubator or research lab, the next step will be commercializing it as efficiently and quickly as possible. This means patent application in the major market worldwide, capital investment, management team for a start-up, preclinical trials, further fund raising, FDA filing, formulation, GMP standard product manufacturing, phase 1,2,3 trials, liscensing, Co-development, business development, and etc. We put all these challenging tasks in one system, the accelerator, to make the commercialization a fairly simple process for the scientist. So now the scientist can relax, focus on what he is good at, the research. And we will take care of the rest.
Patent: Once entered the accelerator, if the university couldn't apply patent abroad, we will take cate of it
Investment: We will allocate capital investment to support the start-up
Start-up: We will assemble a professional management team to run the start-up
Preclinical: We will arrange preclinical trials in our partnered facility
Fund raising: a professional team will expose the start-up to many fund raising opportunities
FDA Filing: We provide regulatory affair team, medical expert, biostatistics team to work together on FDA filing
We provide formulation expert, and will arrange GMP standard manufecturing
Work with our partners to conduct clinical trials local or world wide
Professional team to help on liscensing, co-development and other business development opportunities.
Shifield Investment team is a specialized Sino-American transatlantic healthcare investor. We invests in both innovative healthcare technology companies as well as pharmaceutical companies with mid-late stage new drugs. The Shifield investment team have fund invests in the following businesses:
Active in medical technology, digital health or therapeutics
Early revenue stage or advanced clinical stage
Investments up to $35 million of equity per portfolio company
Europe and the United States
Shifield International Group differentiates itself through its deep sector knowledge in healthcare. We have a network of operational partners and advisors who are top specialists in their fields of expertise. We believe optimal value creation in healthcare is associated with better care at lower costs. Shifield International Group is actively involved in its portfolio companies. We provide hands-on support to our managers in designing the growth strategy and by contributing expertise in specific domains. By investing in companies with clear, achievable business models, we creates significant value for both its investors and the entrepreneurs it backs.